An interventional study of Anthocyanin-rich berry extract and Anthocyanin-rich flower/leaf extract in Stem Cell Surveillance, sponsored by Natural Immune Systems Inc. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-14.
Sponsored by Natural Immune Systems Inc · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal for this clinical trial is to compare acute immune effects of three nutraceutical ingredients and blends to a placebo.
The goal for this clinical trial is to compare acute immune effects of anthocyanin-rich botanical extracts and blends to a placebo.
Stem cell mobilization and homing will be evaluated through monitoring of changes to the numbers of various types of stem cells in the blood circulation.
The testing will show whether consuming the active test products lead to changes in stem cell numbers in circulation above the normal circadian changes for each participant. The normal circadian changes are documented on the clinic visit where placebo is consumed. Several different stem cell populations will be evaluated using flow cytometry.
Natural Immune Systems Inc is the lead sponsor of 25 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Willing to comply with study procedures, including:
Exclusion Criteria:
Prescription medication will be evaluated on a case-by-case basis.
Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 5 weeks, in this order: A, B, C, D.
Dietary Supplement: Anthocyanin-rich berry extract · Dietary Supplement: Anthocyanin-rich flower/leaf extract · Dietary Supplement: Berry /leaf blend · Dietary Supplement: Placebo
Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 5 weeks, in this order: B, C, D, A.
Dietary Supplement: Anthocyanin-rich berry extract · Dietary Supplement: Anthocyanin-rich flower/leaf extract · Dietary Supplement: Berry /leaf blend · Dietary Supplement: Placebo
Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 5 weeks, in this order: C, D. A, B.
Dietary Supplement: Anthocyanin-rich berry extract · Dietary Supplement: Anthocyanin-rich flower/leaf extract · Dietary Supplement: Berry /leaf blend · Dietary Supplement: Placebo
Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 5 weeks, in this order: D, A, B, C.
Dietary Supplement: Anthocyanin-rich berry extract · Dietary Supplement: Anthocyanin-rich flower/leaf extract · Dietary Supplement: Berry /leaf blend · Dietary Supplement: Placebo
0.5 grams
0.5 grams
0.5 grams
Placebo (white rice-based)
Stem cell surveillance
Changes to the number of stem cells in the blood circulation (number of cells per mL blood). Data is collected on the following types of stem cells: CD45dimCD34+CD309+, CD45dimCD34+CD309-, CD31++CD34-, CD45-CD90+.
Time frame: Baseline, 1 hour, 2 hours after consumption
Serum cytokine levels
Time frame: Baseline, 1 hour, 2 hours after consumption
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2026; primary completion for Jan 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Natural Immune Systems Inc